Patents by Inventor Michelle Zawadski

Michelle Zawadski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thienylindole azepines as serotonin 5-HTreceptor ligands and uses thereof
    Patent number: 9309262
    Abstract: The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are thienylindole azepines. These compounds are serotonin receptor (5-HT2c) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT2c) is desired (e.g. addiction, anxiety, depression, obesity, and others).
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: April 12, 2016
    Assignee: ABT Holding Company
    Inventors: Michael Robarge, Michelle Zawadski, John Harrington
  • THIENYLINDOLE AZEPINES AS SEROTONIN 5-HT2C RECEPTOR LIGANDS AND USES THEREOF
    Publication number: 20140275035
    Abstract: The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are thienylindole azepines. These compounds are serotonin receptor (5-HT2c) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT2c) is desired (e.g. addiction, anxiety, depression, obesity, and others).
    Type: Application
    Filed: March 7, 2014
    Publication date: September 18, 2014
    Applicant: ABT Holding Company
    Inventors: Michael Robarge, Michelle Zawadski, John Harrington